38206-85-8 Usage
Uses
Used in Pharmaceutical Synthesis:
2-(quinuclidin-3-yl)acetic acid is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique structure and reactivity allow for the creation of new drug molecules with potential therapeutic benefits.
Used in Organic Chemistry:
In the field of organic chemistry, 2-(quinuclidin-3-yl)acetic acid serves as a versatile building block for the synthesis of a wide range of organic molecules. Its presence in the structure of these molecules can impart novel properties and functionalities.
Used in Medical Research:
2-(quinuclidin-3-yl)acetic acid is used as a subject of study in medical research for its potential use in treating various medical conditions. Its pharmacological activities are being explored to understand its therapeutic potential and to develop new treatments.
Used in Drug Development:
As a compound with potential pharmacological activities, 2-(quinuclidin-3-yl)acetic acid is utilized in drug development processes. Researchers aim to leverage its properties to create new drugs that can address unmet medical needs.
Used in Medicinal Chemistry:
In medicinal chemistry, 2-(quinuclidin-3-yl)acetic acid is employed as a starting material for the design and synthesis of new bioactive compounds. Its unique structural features make it a promising candidate for the development of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 38206-85-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,2,0 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 38206-85:
(7*3)+(6*8)+(5*2)+(4*0)+(3*6)+(2*8)+(1*5)=118
118 % 10 = 8
So 38206-85-8 is a valid CAS Registry Number.
38206-85-8Relevant academic research and scientific papers
Glucosylceramide synthase inhibitors
-
, (2015/09/28)
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
ATX MODULATING AGENTS
-
Page/Page column 98; 117; 118, (2015/12/24)
Compounds of formula (I) can modulate the activity of autotaxin (ATX).
(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]-octane as potent agonists for the α7 nicotinic acetylcholine receptor
Tatsumi, Ryo,Seio, Kohji,Fujio, Masakazu,Katayama, Jiro,Horikawa, Takashi,Hashimoto, Kenji,Tanaka, Hiroshi
, p. 3781 - 3784 (2007/10/03)
A series of 3-substituted 1-azabicyclo[2.2.2]octanes was discovered as the α7 nicotinic acetylcholine (α7) receptor agonists. It was found that (+)-3-[2-(benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane (+)-15b has potent agonistic activity for the α7 receptor.
New 5-HT3 (serotonin-3) receptor antagonists. IV. Synthesis and structure-activity relationships of azabicycloalkaneacetamide derivatives.
Kato,Ito,Nishino,Yamakuni,Takasugi
, p. 1351 - 1357 (2007/10/02)
The synthesis and structure-activity relationships of a series of new azabicycloalkanes as 5-HT3 (serotonin-3) receptor antagonists are described. Our study on the azabicycloalkaneacetamide derivatives showed that 2,3-dihydroindole as the aromatic ring mo
